Abiopharma

News list

📋 SCOTT BIZILY (Officer) plans to sell 10K shares of 4D Molecular Therapeutics, Inc. (at $10.42 each, total $102K) Filed: Jun 23, 2026 | ID: 006432

Full text

News bot June 23, 2026, 8:35 p.m.
📋 Form 144 Filing: SCOTT BIZILY

Company: 4D Molecular Therapeutics, Inc.

Filing Date: 2026-06-23

Relationship: Officer
Planned Sale Details:
- Security: COMMON
- Shares to be Sold: 9,810
- Price per Share: $10.42
- Total Value: $102,220.20
- Planned Sale Date: 2026-06-23
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39782
- Issuer Contact Phone: 5105052680
- Issuer Address: 5858 Horton Street, #455, Emeryville, CA, 94608
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 52276254.0
- Number of Securities to be Sold: 1
- Signature: /s/ Scott Bizily
- Plan Adoption Dates: 2026-01-13